APA (7th ed.) Citation

L, Z., J, Z., W, Z., & H, Z. (2025). Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies. Molecular neurobiology, 63(1), 231. https://doi.org/10.1007/s12035-025-05424-0

Chicago Style (17th ed.) Citation

L, Zhang, Zhao J, Zhang W, and Zhang H. "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies." Molecular Neurobiology 63, no. 1 (2025): 231. https://doi.org/10.1007/s12035-025-05424-0.

MLA (9th ed.) Citation

L, Zhang, et al. "Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Alzheimer's Disease: Recent Advances and Controversies." Molecular Neurobiology, vol. 63, no. 1, 2025, p. 231, https://doi.org/10.1007/s12035-025-05424-0.